1. Home
  2. AVTX vs SMID Comparison

AVTX vs SMID Comparison

Compare AVTX & SMID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • SMID
  • Stock Information
  • Founded
  • AVTX 2011
  • SMID 1960
  • Country
  • AVTX United States
  • SMID United States
  • Employees
  • AVTX N/A
  • SMID N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • SMID Building Materials
  • Sector
  • AVTX Health Care
  • SMID Industrials
  • Exchange
  • AVTX Nasdaq
  • SMID Nasdaq
  • Market Cap
  • AVTX 248.3M
  • SMID 206.7M
  • IPO Year
  • AVTX 2015
  • SMID 1995
  • Fundamental
  • Price
  • AVTX $15.14
  • SMID $37.81
  • Analyst Decision
  • AVTX Strong Buy
  • SMID
  • Analyst Count
  • AVTX 9
  • SMID 0
  • Target Price
  • AVTX $30.14
  • SMID N/A
  • AVG Volume (30 Days)
  • AVTX 412.1K
  • SMID 10.3K
  • Earning Date
  • AVTX 11-06-2025
  • SMID 11-13-2025
  • Dividend Yield
  • AVTX N/A
  • SMID N/A
  • EPS Growth
  • AVTX N/A
  • SMID 81.92
  • EPS
  • AVTX N/A
  • SMID 2.22
  • Revenue
  • AVTX $192,000.00
  • SMID $88,866,000.00
  • Revenue This Year
  • AVTX N/A
  • SMID N/A
  • Revenue Next Year
  • AVTX N/A
  • SMID N/A
  • P/E Ratio
  • AVTX N/A
  • SMID $17.08
  • Revenue Growth
  • AVTX N/A
  • SMID 16.37
  • 52 Week Low
  • AVTX $3.39
  • SMID $25.13
  • 52 Week High
  • AVTX $19.41
  • SMID $51.96
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 48.12
  • SMID 52.54
  • Support Level
  • AVTX $14.16
  • SMID $37.08
  • Resistance Level
  • AVTX $16.03
  • SMID $40.00
  • Average True Range (ATR)
  • AVTX 1.27
  • SMID 2.04
  • MACD
  • AVTX -0.42
  • SMID 0.04
  • Stochastic Oscillator
  • AVTX 23.40
  • SMID 38.13

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

Share on Social Networks: